We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Blood Test for Presence of Autoimmune Antibodies Could Help Identify COVID-19 Patients at Risk of Developing Severe Disease

By LabMedica International staff writers
Posted on 10 Sep 2021
Print article
Image: Blood Test for Presence of Autoimmune Antibodies Could Help Identify COVID-19 Patients at Risk of Developing Severe Disease (Photo courtesy of Life Science Alliance)
Image: Blood Test for Presence of Autoimmune Antibodies Could Help Identify COVID-19 Patients at Risk of Developing Severe Disease (Photo courtesy of Life Science Alliance)
A new study has detected special immune system defense molecules, called autoimmune antibodies, in the blood of more than a third of men and women on admission to hospital and confirmed to have COVID-19.

Among the findings of the study by researchers at NYU Grossman School of Medicine (New York, NY, USA) is that a subset of these autoimmune antibodies that bind to DNA or to a particular type of fat molecule, a lipid called phosphatidylserine, were more often twice as abundant at the start of coronavirus infection in those whose conditions worsened quickly than in those whose health did not decline. Patients with these elevated levels of autoimmune antibodies were five to seven times more likely to develop severe disease than those whose antibodies levels were stable.

People hospitalized with life-threatening cases of COVID-19, researchers say, required intensive care and a mechanical ventilator to help them breathe while those who had lower levels of these autoantibodies usually breathed on their own and largely recovered. The latest work is based on the nature of antibodies, immune proteins that target invading bacteria and viruses. By contrast, autoimmune antibodies attack an infected person’s own cells and molecules. This includes lipids and genetic material, or DNA, which are known to spill into the bloodstream as cells are killed by disease, such as COVID-19.

For the new study, researchers examined the medical records and blood tests from 115 White, Black, Asian, and Hispanic men and women hospitalized for COVID-19 at NYU Langone hospitals between April and June 2020. Roughly equal numbers had severe disease from which they either survived or died, or did not require intensive care and recovered quickly. Test results for more than 100 measurements, such as blood oxygen levels, liver enzymes, and kidney function, were compared with levels of autoimmune antibodies. The researchers designed the analysis to learn whether common autoimmune antibodies were present in COVID-19, as other studies in other infectious diseases had already suggested, and whether or not variations in blood levels were tied to how sick people became.

The researchers found that 36% of the study participants had autoimmune antibodies when they were admitted to the hospital. Levels of anti-DNA and anti-phosphatidylserine antibodies were then strongly linked to severity of illness. Specifically, 86% and 93% of patients with high levels of anti-DNA and anti-phosphatidylserine antibodies, respectively, experienced severe COVID-19. Levels of anti-DNA antibodies were also linked to increases in blood coagulation (thrombosis) and cell death (lysis), especially in muscle tissue. Researchers say both thrombosis, which can lead to life-threatening blood clots, and damage to muscle tissue, especially in the heart, have been observed in the most serious cases of COVID-19.

Further experiments will be needed to determine if autoimmune antibodies are indeed the “cause or effect” of the blood clotting and cell lysis observed in her team’s study. If found to be causal of cell damage, new COVID-19 treatments could include antibody injections from healthy donors to dilute the presence of autoimmune antibodies. Other experimental therapies under consideration involve biodegradable antigens that attach to autoimmune antibodies and neutralize them, but do not lead to a lasting antibody immune reaction of their own.

“Our study results show that initial blood levels of anti-DNA or anti-phosphatidylserine antibodies were directly linked to the severity of illness in those with COVID-19,” said study co-lead investigator Claudia Gomes, PhD, a postdoctoral fellow at NYU Langone Health.

“While further testing is needed, our findings suggest that a test for the presence of anti-DNA and anti-phosphatidylserine antibodies could help identify those COVID-19 patients admitted to hospital who are most at risk of needing intensive care and who need to be monitored more closely,” added Marisol Zuniga, MS, also a study co-lead investigator at NYU Langone.


Related Links:
NYU Grossman School of Medicine

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Sulfidoleukotrienes (sLT) Assay
CAST ELISA
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more